News: FDA’s Rapid Approval of Esketamine for Severe Depression Questioned Medscape News Pauline Anderson November 13, 2019 https://www.medscape.com/viewarticle/921248#vp_1 While some experts have hailed intranasal esketamine (Spravato, Janssen) as a “game changer” for treatment-resistant depression (TRD), others are concerned over the US Food and Drug Administration’s (FDA) rapid approval of the drug. In an editorial Read More …
Category: Ketamine Research
RESTORE – The 90-Minute Transformation
New Ketamine Institute Physician Graduates
Ketamine Institute Training Program for Physicians The Ketamine Institute is proud to announce that we have just graduated new physicians qualified to safely and effectively perform ketamine infusion therapy for patients with mood disorders. These physicians have completed the only comprehensive training program in the use of ketamine therapy for physicians in North America and Read More …